Interrupted time-series analysis reveals suboptimal osteoporosis medication use in hospitalized hip fracture patients, suggesting a need for improved policies.
Japan's secondary fracture prevention reimbursement policy successfully improved in-hospital initiation of osteoporosis treatment among patients with hip fracture. Nevertheless, actual usage of osteoporosis medications with robust evidence for fracture prevention remains suboptimal. Effective prevention of secondary fractures and improved patient outcomes require appropriate medication selection, potentially facilitated by supportive policy measures.
No takes yet. Share an insight, caveat, or question.
Fujiwara et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: